h.hutchings
TL1 Member · Sheffield, UK
Newer member working through the reference pages before asking anything.
Joined 27 March 2025 · last posted 1mo
24 posts, newest first. Showing up to 150.
-
Naming conventions for research peptides and the confusion they cause Replied, post #19 · Compounds › Other compounds · 22 Jun 2026 · 12 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #44 · Analytics › Method validation · 6 Jun 2026 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #49 · Compounds › Semaglutide · 3 Jun 2026 · 9 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #9 · Analytics › HPLC & UHPLC · 12 May 2026 · 4 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Journal club: is percentage weight change the right endpoint? Replied, post #110 · Evidence › Journal club · 27 Apr 2026 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Grapefruit: why this class is not the class that cares Replied, post #125 · Practice › Interactions · 6 Apr 2026 · 0 likes Picking up post #122: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Second pass at: Submitting a sample: the process end to end Replied, post #14 · Sourcing › Independent verification · 16 Mar 2026 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Journal club: PIONEER 6 as a safety trial Replied, post #15 · Evidence › Journal club · 26 Jan 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
DXA precision and the least significant change for lean mass Replied, post #42 · Outcomes › Body composition · 4 Dec 2025 · 4 likes Worth separating two things that post #38 runs together. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #96 · Practice › Administration · 6 Oct 2025 · 2 likes On post #92 — agreed on the reasoning, with one qualification. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in…
-
Documentation that materially improves an appeal's chances Replied, post #15 · Access › Insurance & coverage · 1 Oct 2025 · 0 likes This follows post #12 rather than contradicting it. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by…
-
When to stop reading forums, including this one Replied, post #28 · Wellbeing › Mental health · 22 Sep 2025 · 28 likes Picking up post #25: that is the part I would want checked first. Body image and weight loss: large weight loss changes a person's relationship with their body in ways…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #83 · Evidence › Trials · 30 Aug 2025 · 25 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #26 · Compounds › Oral incretins · 16 Aug 2025 · 0 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #4 · Evidence › Journal club · 8 Aug 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #34 · Devices › Syringes & needles · 6 Jul 2025 · 26 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Preservatives: function, testing, and limits Replied, post #21 · Pharmacology › Formulation chemistry · 17 Mar 2025 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #65 · Pharmacology › Receptor biology · 9 Mar 2025 · 30 likes This follows post #62 rather than contradicting it. Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #19 · Start Here › Welcome · 31 Dec 2024 · 15 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #27 · Compounds › Semaglutide · 22 Dec 2024 · 23 likes post #26 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Coming back to: When to suspect the method rather than the sample Replied, post #58 · Analytics › Method validation · 11 Dec 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Chronic kidney disease and the FLOW result — a second dataset Replied, post #3 · Clinical › Comorbidities · 16 Nov 2024 · 30 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #121 · Clinical › Bloodwork · 18 Oct 2024 · 32 likes post #120 is right about the mechanism and I think understates the practical bit. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from…
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #10 · Practice › Administration · 2 Aug 2024 · 10 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…